TL;DR
This paper reviews current knowledge on Hepatitis B Virus (HBV) transmission during pregnancy, emphasizing the critical role of mother-to-child transmission (MTCT). It highlights that while HBV infection itself doesn't typically affect fertility, managing pregnant carriers is crucial to prevent chronic infection in newborns, with a clear protocol for screening, vaccination, and antiviral treatment.
What Problem Does This Paper Address?
Hepatitis B Virus (HBV) is a significant global health concern, with millions of chronic carriers worldwide. A substantial portion of these chronic infections originate from mother-to-child transmission (MTCT). This paper addresses the challenge of preventing HBV transmission from infected pregnant mothers to their infants. It aims to consolidate current understanding and provide a clear overview of the risks, transmission routes, and recommended management strategies for pregnant women with HBV, ensuring newborns receive timely prophylaxis to prevent chronic infection.
Methods
This paper is a review article, synthesizing information from existing literature. It does not present novel experimental data or introduce new algorithms. The "methods" employed are literature review, analysis of existing studies, and the compilation of current clinical guidelines and recommendations from organizations like the American Association for the Study of Liver Disease (AASLD) and the American Congress of Obstetricians and Gynecologists (ACOG).
Datasets
Not discussed in the paper.
Key Insights and Ideas
- MTCT is a Major Driver of Chronic HBV: Roughly half of all chronic HBV carriers acquired the infection vertically from their mothers.
- High Risk of Chronicity in Infants: Infants infected vertically have a very high chance (up to 90%) of developing chronic HBV infection.
- Multiple Transmission Routes: HBV can be transmitted during pregnancy (in-utero), during delivery, and postpartum (including breastfeeding).
- Delivery is the Most Common MTCT Route: While in-utero transmission is possible, transmission during the birthing process is the most frequent mode.
- Effective Prevention Strategies Exist: Neonatal administration of Hepatitis B Immune Globulin (HBIG) and the HBV vaccine is highly effective (over 85%) in preventing newborn HBV infection.
- Antiviral Therapy for High-Risk Mothers: For pregnant women with high HBV viral loads or HBeAg positivity, antiviral treatment (like tenofovir) is recommended to reduce MTCT.
- Cesarean Section Not Solely for HBV: Cesarean sections should only be performed for obstetric indications, not solely because the mother is HBV positive.
- Breastfeeding is Generally Safe: With appropriate immunoprophylaxis for the infant, breastfeeding is considered safe.
- Mandatory Screening is Essential: All pregnant women should be screened for Hepatitis B.
Key Results
- Neonatal administration of HBIG with vaccination can prevent newborn HBV infection in more than 85% of cases.
- In the absence of prophylaxis, infants born to HBeAg-positive mothers have a 70%-90% risk of chronic HBV infection, while those born to HBeAg-negative mothers have a 10%-40% risk.
- A meta-analysis suggests a 17.5% absolute risk reduction in MTCT with elective cesarean section compared to immunoprophylaxis alone, though this is not a sole indication for C-section.
- Studies indicate that HBV DNA levels > 2 X 10^5 IU/ml are an indication for initiating antiviral therapy during pregnancy.
Limitations and Future Work
Limitations: * The paper acknowledges that its discussion of in-utero transmission is based on limited data, and the exact impact of this mode is unclear. * It notes that the paper does not discuss potential barriers to HBV screening and vaccination in low-resource settings.
Future Work: * The authors suggest future research could focus on developing universal immunization programs. * Exploring the use of novel antiviral agents in pregnancy is also mentioned. * Investigating the long-term outcomes of infants exposed to HBV during pregnancy is another area for future research.
Summary updated